← Open Payments lookup

KAREN KINDLER: Open Payments

NPI 1326002205 · FORT WORTH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,356 in 86 payments from 11 companies in 2025. Trend: 2023 $1,496 · 2024 $2,068 · 2025 $2,356

Food & beverage: $2,356
CompanyPaymentsAmount
Madrigal Pharmaceuticals15$536
Ipsen Biopharmaceuticals, Inc12$482
Gilead Sciences, Inc.17$397
ABBVIE INC.13$243
Salix Pharmaceuticals, a division of Bausch Health US, LLC9$201
Novo Nordisk Inc5$194
Mallinckrodt Hospital Products Inc.6$149
Intercept Pharmaceuticals, Inc.5$83
Mirum Pharmaceuticals, Inc.2$34
Aimmune Therapeutics, Inc.1$19

Products named: REZDIFFRA, IQIRVO, MAVYRET, XIFAXAN, Wegovy, TERLIVAZ, OCALIVA, Livmarli.

Industry payments across TX — which companies pay providers there.